105 related articles for article (PubMed ID: 6742932)
1. Growth inhibition of Leishmania tropica amastigotes in vitro by rifampicin combined with amphotericin B.
El-On J; Messer G; Greenblatt CL
Ann Trop Med Parasitol; 1984 Apr; 78(2):93-8. PubMed ID: 6742932
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapeutic activity of rifampicin on leishmanial amastigotes and promastigotes in vitro.
El-On J; Pearlman E; Schnur LF; Greenblatt CL
Isr J Med Sci; 1983 Mar; 19(3):240-5. PubMed ID: 6853121
[TBL] [Abstract][Full Text] [Related]
3. Infection and replication of Leishmania tropica in mouse peritoneal macrophages elicited by sterile inflammatory agents and BCG.
Pappas MG
Am J Trop Med Hyg; 1983 Sep; 32(5):952-9. PubMed ID: 6625076
[TBL] [Abstract][Full Text] [Related]
4. In vitro synergistic effect of amphotericin B and allicin on Leishmania donovani and L. infantum.
Corral MJ; González-Sánchez E; Cuquerella M; Alunda JM
Antimicrob Agents Chemother; 2014; 58(3):1596-602. PubMed ID: 24366748
[TBL] [Abstract][Full Text] [Related]
5. Intracellular destruction of Leishmania donovani and Leishmania tropica amastigotes by activated macrophages: dissociation of these microbicidal effector activities in vitro.
Hockmeyer WT; Walters D; Gore RW; Williams JS; Fortier AH; Nacy CA
J Immunol; 1984 Jun; 132(6):3120-5. PubMed ID: 6725948
[TBL] [Abstract][Full Text] [Related]
6. Combined effect of amphotericin B and rifampin on Candida species.
Edwards JE; Morrison J; Henderson DK; Montgomerie JZ
Antimicrob Agents Chemother; 1980 Mar; 17(3):484-7. PubMed ID: 7425608
[TBL] [Abstract][Full Text] [Related]
7. Effect of amphotericin B alone or in combination with rifampicin or clarithromycin against Candida species biofilms.
Del Pozo JL; Francés ML; Hernáez S; Serrera A; Alonso M; Rubio MF
Int J Artif Organs; 2011 Sep; 34(9):766-70. PubMed ID: 22094555
[TBL] [Abstract][Full Text] [Related]
8. Intracellular replication of Leishmania tropica in mouse peritoneal macrophages: comparison of amastigote replication in adherent and nonadherent macrophages.
Nacy CA; Diggs CL
Infect Immun; 1981 Oct; 34(1):310-3. PubMed ID: 7298191
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol is active against Leishmania amazonensis: in vitro effect of its association with Amphotericin B.
Ferreira C; Soares DC; Nascimento MT; Pinto-da-Silva LH; Sarzedas CG; Tinoco LW; Saraiva EM
Antimicrob Agents Chemother; 2014 Oct; 58(10):6197-208. PubMed ID: 25114129
[TBL] [Abstract][Full Text] [Related]
10. Growth of Leishmania amastigotes in macrophages from normal and immune mice.
Handman E; Spira DT
Z Parasitenkd; 1977 Aug; 53(1):75-81. PubMed ID: 919689
[TBL] [Abstract][Full Text] [Related]
11. Intracellular replication of Leishmania tropica in mouse peritoneal macrophages: amastigote infection of resident cells and inflammatory exudate macrophages.
Fortier AH; Hoover DL; Nacy CA
Infect Immun; 1982 Dec; 38(3):1304-8. PubMed ID: 7152674
[TBL] [Abstract][Full Text] [Related]
12. In vitro 4-Aryloxy-7-chloroquinoline derivatives are effective in mono- and combined therapy against Leishmania donovani and induce mitocondrial membrane potential disruption.
Valdivieso E; Mejías F; Torrealba C; Benaim G; Kouznetsov VV; Sojo F; Rojas-Ruiz FA; Arvelo F; Dagger F
Acta Trop; 2018 Jul; 183():36-42. PubMed ID: 29604246
[TBL] [Abstract][Full Text] [Related]
13. The experimental chemotherapy of leishmaniasis. I: Techniques for the study of drug action in tissue culture.
Mattock NM; Peters W
Ann Trop Med Parasitol; 1975 Sep; 69(3):349-57. PubMed ID: 1171658
[TBL] [Abstract][Full Text] [Related]
14. New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp.
Ruiz HK; Serrano DR; Dea-Ayuela MA; Bilbao-Ramos PE; Bolás-Fernández F; Torrado JJ; Molero G
Int J Pharm; 2014 Oct; 473(1-2):148-57. PubMed ID: 24998510
[TBL] [Abstract][Full Text] [Related]
15. Depletion of secondary lysosomes in mouse macrophages infected with Leishmania mexicana amazonensis: a cytochemical study.
Barbieri CL; Brown K; Rabinovitch M
Z Parasitenkd; 1985; 71(2):159-68. PubMed ID: 3993184
[TBL] [Abstract][Full Text] [Related]
16. Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus Viannia.
Franco-Muñoz C; Manjarrés-Estremor M; Ovalle-Bracho C
PLoS One; 2018; 13(4):e0196247. PubMed ID: 29698432
[TBL] [Abstract][Full Text] [Related]
17. Intracellular replication and lymphokine-induced destruction of Leishmania tropica in C3H/HeN mouse macrophages.
Nacy CA; Meltzer MS; Leonard EJ; Wyler DJ
J Immunol; 1981 Dec; 127(6):2381-6. PubMed ID: 7299130
[TBL] [Abstract][Full Text] [Related]
18. Antileishmanial activity of a new 8-hydroxyquinoline derivative designed 7-[5'-(3'-phenylisoxazolino)methyl]-8-hydroxyquinoline: preliminary study.
Dardari Z; Lemrani M; Bahloul A; Sebban A; Hassar M; Kitane S; Berrada M; Boudouma M
Farmaco; 2004 Mar; 59(3):195-9. PubMed ID: 14987982
[TBL] [Abstract][Full Text] [Related]
19. In-vitro effects of Candida albicans of amphotericin B combined with other antibiotics. Preliminary observations.
Anséhn S; Granström S; Höjer H; Nilsson L; Akesson E; Lundin A; Thore A
Scand J Infect Dis Suppl; 1976; (9):62-6. PubMed ID: 795012
[TBL] [Abstract][Full Text] [Related]
20. In-vitro sensitivity of Pakistani Leishmania tropica field isolate against buparvaquone in comparison to standard anti-leishmanial drugs.
Jamal Q; Khan NH; Wahid S; Awan MM; Sutherland C; Shah A
Exp Parasitol; 2015 Jul; 154():93-7. PubMed ID: 25911243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
